Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials

Headache

Volumn 42, Issue SUPPL. 1, 2002, Pages 32-37

  Mathew, Ninan T ^a  

^a Houston Headache Clinic   (United States)

Author keywords

Almotriptan; Migraine; Pain freedom; Sumatriptan

Indexed keywords

ALMOTRIPTAN;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0036169597     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.0420s1032.x     Document Type: Conference Paper

References (16)

1. Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy
2. Current and emerging second-generation triptans in acute migraine therapy: A comparative review
3. Acute migraine treatment outcome measures: A clinician's view
4. Guidelines for controlled trials of drugs in migraine: Second edition
5. Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine
6. Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: Results of a large, randomized, double-blind, placebo-controlled study
7. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
8. Burden of migraine: Societal costs and therapeutic opportunities
9. Diagnosis and treatment of migraine
10. Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum Study
11. New triptan preparations can help the migraine patient. Pharmacodynamic and pharmacokinetic progresses
12. Low migraine headache recurrence with naratriptan: Clinical parameters related to recurrence
13. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy?
14. Determinants of patient satisfaction with migraine therapy
15. An assessment of the burden of migraine using the willingness to pay model
16. Acute migraine treatment: Factors affecting therapeutic decision making